Long-term follow-up of open commissurotomy versus bileaflet valve replacement for rheumatic mitral stenosis

Eur J Cardiothorac Surg. 1997 Sep;12(3):335-9; discussion 339-40. doi: 10.1016/s1010-7940(97)00197-8.

Abstract

Objective: Despite the achievements of third generation mechanical cardiac valve prostheses, conservative procedures are still considered the best surgical option for rheumatic mitral valve stenosis. To compare long-term results of open mitral commissurotomy (Group A) and mitral valve replacement with bileaflet prostheses (Group B) a 15-year follow-up study was carried out.

Methods: From January 1981 to May 1996, 540 consecutive patients with pure isolated rheumatic mitral stenosis underwent mitral valve surgery: 300 had mitral commissurotomy and 240 valve replacement. The follow-up was 99.05% complete and ranged between 1 and 185 months in Group A and from 1 to 171 months in Group B.

Results: Hospital mortality was 2% in Group A and 2.08% in Group B. Late mortality was 1% in Group A and 3% in Group B. The 10-year survival rates were 98.7% +/- 1% in Group A and 93.7% +/- 3% in Group B. There was a statistically significant difference of freedom from reoperation in Group B (97.7% +/- 1%) versus Group A (88.1% +/- 2%) (P = 0.04). In group A 14 embolic events occurred (93.7% +/- 2%), and 15 (6.52%) in Group B (83.9% +/- 7%). Haemorrhagic events were observed in 2 patients (0.68%) of Group A (99.3% +/- 0.5%) and in 3 patients (1.3%) of Group B (98.4% +/- 1%).

Conclusions: Long term results of mitral commissurotomy were more satisfactory than those obtained with bileaflet valves. Reoperation rate was higher in mitral commissurotomy.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Embolism / etiology
  • Female
  • Follow-Up Studies
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / mortality
  • Heart Valve Prosthesis Implantation / standards*
  • Hospital Mortality
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Stenosis / microbiology*
  • Mitral Valve Stenosis / surgery*
  • Postoperative Hemorrhage / etiology
  • Reoperation
  • Rheumatic Heart Disease / complications*
  • Survival Analysis
  • Treatment Outcome